CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in fireside chats at the following upcoming investor conferences:
Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences
Seeking Alpha / 1 hour from now 1 Views
Comments